KWANGDONG PHARMACEUTICAL CO.,LTD Logo

KWANGDONG PHARMACEUTICAL CO.,LTD

Develops and sells pharmaceuticals, health-oriented beverages, and supplements.

009290 | KO

Overview

Corporate Details

ISIN(s):
KR7009290008
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7다길 52 광동 과천 타워, 과천시

Description

Kwangdong Pharmaceutical is a human healthcare company that develops, manufactures, and sells a diverse range of products, including pharmaceuticals and health-oriented beverages. Founded on the principle of the 'scientification of Oriental medicine,' the company integrates traditional Korean medicinal concepts with modern Western science. Its portfolio includes Over-the-Counter (OTC) and prescription (ETC) drugs, general health supplements, and traditional health foods. The company is also prominent in the consumer market with its popular beverage lines, featuring well-known products such as the Vita 500 vitamin drink and Corn Silk Tea. Additionally, Kwangdong is involved in the distribution of mineral water.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-26 00:00
정기주주총회결과
Korean 26.6 KB
2025-03-26 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-03-25 00:00
[기재정정]사업보고서 (2024.12)
Korean 4.1 MB
2025-03-20 00:00
[기재정정]사업보고서 (2024.12)
Korean 4.7 MB
2025-03-18 00:00
감사보고서제출
Korean 19.5 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 4.1 MB
2025-02-25 00:00
주주총회소집공고
Korean 1.4 MB
2025-02-25 00:00
의결권대리행사권유참고서류
Korean 1.4 MB
2025-02-24 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.0 KB
2025-02-20 00:00
최대주주등소유주식변동신고서
Korean 52.0 KB
2025-02-19 00:00
주식등의대량보유상황보고서(약식)
Korean 103.0 KB
2025-02-17 00:00
주주총회소집결의
Korean 13.8 KB
2025-02-17 00:00
기타경영사항(자율공시)
Korean 4.2 KB
2025-02-17 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.8 KB
2025-02-17 00:00
현금ㆍ현물배당결정
Korean 8.6 KB

Automate Your Workflow. Get a real-time feed of all KWANGDONG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KWANGDONG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KWANGDONG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.